Michelle Patricia Aranha, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Outer Membrane Proteins | 3 | 2021 | 403 | 1.200 |
Why?
|
| Streptococcal Vaccines | 3 | 2023 | 45 | 1.130 |
Why?
|
| Antigens, Bacterial | 3 | 2021 | 1146 | 1.080 |
Why?
|
| Peptides | 4 | 2021 | 4331 | 0.960 |
Why?
|
| Cross Reactions | 2 | 2021 | 824 | 0.790 |
Why?
|
| Streptococcus pyogenes | 3 | 2023 | 295 | 0.780 |
Why?
|
| Vaccines, Synthetic | 2 | 2021 | 621 | 0.710 |
Why?
|
| Antibodies, Bacterial | 3 | 2021 | 1476 | 0.590 |
Why?
|
| Carrier Proteins | 3 | 2021 | 4913 | 0.580 |
Why?
|
| Lipid Bilayers | 1 | 2020 | 376 | 0.580 |
Why?
|
| Titanium | 1 | 2020 | 490 | 0.550 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 431 | 0.540 |
Why?
|
| Antigens | 1 | 2020 | 1438 | 0.470 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2020 | 1365 | 0.420 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 3837 | 0.310 |
Why?
|
| Epitopes | 3 | 2021 | 2523 | 0.250 |
Why?
|
| Boron Compounds | 1 | 2025 | 196 | 0.210 |
Why?
|
| Protein Conformation | 2 | 2020 | 3946 | 0.200 |
Why?
|
| Glycine | 1 | 2025 | 672 | 0.180 |
Why?
|
| Rabbits | 3 | 2023 | 4734 | 0.170 |
Why?
|
| Adhesiveness | 1 | 2020 | 52 | 0.170 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2020 | 340 | 0.170 |
Why?
|
| Molecular Conformation | 1 | 2020 | 541 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2020 | 13400 | 0.150 |
Why?
|
| Protein Binding | 2 | 2020 | 9296 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2025 | 1963 | 0.140 |
Why?
|
| Algorithms | 4 | 2023 | 14071 | 0.130 |
Why?
|
| Crystallography, X-Ray | 1 | 2020 | 1947 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 3051 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2020 | 2721 | 0.100 |
Why?
|
| Animals | 7 | 2023 | 168764 | 0.090 |
Why?
|
| Mice | 4 | 2023 | 81819 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2020 | 5379 | 0.090 |
Why?
|
| Alleles | 1 | 2020 | 6897 | 0.080 |
Why?
|
| Computational Biology | 1 | 2020 | 3559 | 0.080 |
Why?
|
| Multiple Myeloma | 2 | 2025 | 5197 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2659 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 11868 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 70 | 0.050 |
Why?
|
| Africa | 1 | 2023 | 725 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2022 | 639 | 0.040 |
Why?
|
| Disease Progression | 2 | 2025 | 13632 | 0.030 |
Why?
|
| Antibodies | 1 | 2023 | 2417 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2022 | 1587 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 9550 | 0.020 |
Why?
|
| Humans | 4 | 2025 | 765968 | 0.020 |
Why?
|
| Genotype | 1 | 2023 | 13024 | 0.020 |
Why?
|
| Male | 2 | 2025 | 363698 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2022 | 4752 | 0.020 |
Why?
|
| Female | 2 | 2025 | 396112 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16721 | 0.010 |
Why?
|
| Lung | 1 | 2023 | 10033 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 18293 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10850 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 59489 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2025 | 65188 | 0.010 |
Why?
|
| Aged | 1 | 2025 | 171117 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 223009 | 0.010 |
Why?
|
| Adult | 1 | 2025 | 223044 | 0.010 |
Why?
|